103 related articles for article (PubMed ID: 32940666)
1. A study of the immune infiltrate and patient outcomes in esophageal cancer.
Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
[TBL] [Abstract][Full Text] [Related]
2. The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation.
Humphries MP; Craig SG; Kacprzyk R; Fisher NC; Bingham V; McQuaid S; Murray GI; McManus D; Turkington RC; James J; Salto-Tellez M
BMC Cancer; 2020 Jun; 20(1):500. PubMed ID: 32487090
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CD103
Han L; Gao QL; Zhou XM; Shi C; Chen GY; Song YP; Yao YJ; Zhao YM; Wen XY; Liu SL; Qi YM; Gao YF
Cancer Immunol Immunother; 2020 Aug; 69(8):1493-1504. PubMed ID: 32285170
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic characterization of chronic inflammation in a rare case of endobronchial carcinoma.
Gannon PO; Turcotte S; Laporte JL; Saad F; Lapointe R; Duranceau A
Cancer Immunol Immunother; 2010 Sep; 59(9):1411-6. PubMed ID: 20490490
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma.
Zhu Y; Li M; Bo C; Liu X; Zhang J; Li Z; Zhao F; Kong L; Yu J
Cancer Immunol Immunother; 2017 Mar; 66(3):343-354. PubMed ID: 27915370
[TBL] [Abstract][Full Text] [Related]
6. IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma.
Zheng Y; Li Y; Tang B; Zhao Q; Wang D; Liu Y; Guo M; Zhao S; Qi Y; Zhang Y; Huang L
Cancer Immunol Immunother; 2020 Nov; 69(11):2371-2380. PubMed ID: 32524362
[TBL] [Abstract][Full Text] [Related]
7. Characterizing caspase-1 involvement during esophageal disease progression.
Barber G; Anand A; Katarzyna Oficjalska ; Phelan JJ; Heeran AB; Flis E; Clarke NE; Watson JA; Strangmann J; Flood B; O'Neill H; O'Toole D; MacCarthy F; Ravi N; Reynolds JV; Kay EW; Quante M; O'Sullivan J; Creagh EM
Cancer Immunol Immunother; 2020 Dec; 69(12):2635-2649. PubMed ID: 32613271
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma.
Loeser H; Kraemer M; Gebauer F; Bruns C; Schröder W; Zander T; Alakus H; Hoelscher A; Buettner R; Lohneis P; Quaas A
J Immunol Res; 2020; 2020():2862647. PubMed ID: 33029538
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic immune characterization of gastric and esophageal adenocarcinomas reveals profound immune suppression in esophageal tumor locations.
Groen-van Schooten TS; Harrasser M; Seidel J; Bos EN; Fleitas T; van Mourik M; Pouw RE; Goedegebuure RSA; Doeve BH; Sanders J; Bos J; van Berge Henegouwen MI; Thijssen VLJL; van Grieken NCT; van Laarhoven HWM; de Gruijl TD; Derks S
Front Immunol; 2024; 15():1372272. PubMed ID: 38638445
[TBL] [Abstract][Full Text] [Related]
10. Identifying Biomarkers in Lymph Node Metastases of Esophageal Adenocarcinoma for Tumor-Targeted Imaging.
de Gouw DJJM; Rijpkema M; de Bitter TJJ; Baart VM; Sier CFM; Hernot S; van Dam GM; Nagtegaal ID; Klarenbeek BR; Rosman C; van der Post RS
Mol Diagn Ther; 2020 Apr; 24(2):191-200. PubMed ID: 32048177
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer.
Zhang XJ; Yu Y; Zhao HP; Guo L; Dai K; Lv J
World J Gastroenterol; 2024 Apr; 30(16):2195-2208. PubMed ID: 38690024
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy Mechanism of Esophageal Squamous Cell Carcinoma with the Effect of STK11/AMPK Signaling Pathway.
Xia Y; Wang P; Ye Y; Zhang S; Sun G; Xu J; Han G
Biomed Res Int; 2022; 2022():8636527. PubMed ID: 35463992
[TBL] [Abstract][Full Text] [Related]
13. Immune cell infiltrates in peritoneal metastases from colorectal cancer.
Sundström P; Hogg S; Quiding Järbrink M; Bexe Lindskog E
Front Immunol; 2024; 15():1347900. PubMed ID: 38384469
[TBL] [Abstract][Full Text] [Related]
14. Dissecting T-cell heterogeneity in esophageal squamous cell carcinoma reveals the potential role of LAIR2 in antitumor immunity.
Wang P; Zhuang W; Zheng Z; Zhang L; Zhang X; Chen Q
Clin Exp Immunol; 2023 Dec; 214(1):36-49. PubMed ID: 37422711
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease.
Dos Santos Cunha AC; Simon AG; Zander T; Buettner R; Bruns CJ; Schroeder W; Gebauer F; Quaas A
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6917-6929. PubMed ID: 36826594
[TBL] [Abstract][Full Text] [Related]
16. Immune cell-related prognostic risk model and tumor immune environment modulation in esophageal carcinoma based on single-cell and bulk RNA sequencing.
Wen X; Pu L; Wencheng Z; Tengfei M; Guangshun W
Thorac Cancer; 2024 May; 15(14):1176-1186. PubMed ID: 38587029
[TBL] [Abstract][Full Text] [Related]
17. ARID1A Deficiency Regulates Anti-Tumor Immune Response in Esophageal Adenocarcinoma.
Zhang L; Zheng Y; Chien W; Ziman B; Billet S; Koeffler HP; Lin DC; Bhowmick NA
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001638
[TBL] [Abstract][Full Text] [Related]
18. The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma.
Papadakos KS; Gorji-Bahri G; Gialeli C; Hedner C; Hagerling C; Svensson MC; Jeremiasen M; Borg D; Fristedt R; Jirström K; Blom AM
Cancer Immunol Immunother; 2024 Apr; 73(5):93. PubMed ID: 38563861
[TBL] [Abstract][Full Text] [Related]
19. Clinical Significance and Prognostic Implications of Discontinuous Growth Pattern in Esophageal Adenocarcinoma: A Multi-Institutional Study.
Kmeid M; Lee G; Yang Z; Pacheco R; Lin J; Patil DT; Youssef M; Zhang Q; Alkashash AM; Li J; Lee H
Am J Surg Pathol; 2024 Apr; 48(4):447-457. PubMed ID: 38238961
[TBL] [Abstract][Full Text] [Related]
20. Sex disparities revealed by single-cell and bulk sequencing and their impacts on the efficacy of immunotherapy in esophageal cancer.
Yan H; Huang J; Li Y; Zhao B
Biol Sex Differ; 2024 Mar; 15(1):22. PubMed ID: 38491510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
